Fact CheckerSign in

NCT06127641Recruiting

Rehabilitation of People With Post-tuberculosis Lung Disease

Source: ClinicalTrials.gov · Last updated 13 Nov 2023 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Tuberculosis (TB) can leave numerous sequelae, where survivors experience a transition from an acute illness to living with a multifaceted chronic illness. Post-TB lung disease (PD-PTB) encompasses lung diseases and pathologies that occur after one or more episodes of TB, which can affect the patient's lung health and cause disabling symptoms that strongly affect their long-term health. In 2020, it was estimated that there were 155 million TB survivors still alive worldwide, with a large proportion of them carrying functional sequelae with profound socioeconomic repercussions. Thus, the aim of this study is to evaluate the effect of pulmonary rehabilitation (PR) on functionality and health-related quality of life (HRQoL) of people with PD-PTB and to build a PD-PTB severity scoring system based on the data. of pre-RP individuals using artificial intelligence technique.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
40 (estimated)
First submitted
29 Oct 2023
Start date
28 Oct 2023
Primary completion date
31 Dec 2024
Lead sponsor
Centro Universitário Augusto Motta
Diseases
Tuberculosis
NCT number
NCT06127641

What you commit to

  • Study type: Interventional
  • Planned participants: 40
  • From 28 Oct 2023 to the primary completion date, 31 Dec 2024
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Having had any orthopedic surgery in the previous year.

Other illness

  • Uncontrolled hypertension or use of psychotropic medications.

Other

  • Presence of comorbidities not related to PD-PTB.
  • Patients with inability to perform TGlittre.
  • Patients who have cognitive changes that impair their inclusion in the study.
  • Treatment abandonment during the application of the PR protocol.
  • Any significant limitations due to osteoarthropathy.

Who the study is looking for

  • Patients with post-tuberculosis lung disease, clinically stable and able to perform \>80% of training sessions.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Agnaldo José Lopes
Coordinator of this site? Confirm its status
Rio de JaneiroBrazilRecruiting
Centro Universitário Augusto Motta
Coordinator of this site? Confirm its status
Rio de JaneiroBrazilRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.